Xacrel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Xacrel, covering 2022-10-18 to 2022-10-18. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple Sclerosis [Phase 3]